A detailed history of Schroder Investment Management Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schroder Investment Management Group holds 7,626,353 shares of BMY stock, worth $457 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
7,626,353
Previous 6,673,552 14.28%
Holding current value
$457 Million
Previous $277 Million 42.4%
% of portfolio
0.42%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $37.8 Million - $49.3 Million
952,801 Added 14.28%
7,626,353 $395 Million
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $84.6 Million - $111 Million
2,101,253 Added 45.96%
6,673,552 $277 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $53.1 Million - $60.2 Million
1,106,383 Added 31.92%
4,572,299 $248 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $33.8 Million - $40.3 Million
697,388 Added 25.19%
3,465,916 $178 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $41.5 Million - $46.4 Million
-716,893 Reduced 20.57%
2,768,528 $161 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $283 Million - $314 Million
-4,439,679 Reduced 56.02%
3,485,421 $223 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $85.9 Million - $97.5 Million
-1,307,974 Reduced 14.17%
7,925,100 $549 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $26 Million - $30.7 Million
-379,134 Reduced 3.94%
9,233,074 $664 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $43,918 - $26 Million
-337,833 Reduced 3.4%
9,612,208 $683 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $81.6 Million - $89.9 Million
1,123,694 Added 12.73%
9,950,041 $766 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $50.1 Million - $60.1 Million
814,621 Added 10.17%
8,826,347 $646 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $48.1 Million - $56.1 Million
897,369 Added 12.61%
8,011,726 $500 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $21.9 Million - $25.7 Million
370,513 Added 5.49%
7,114,357 $421 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $91.1 Million - $99.2 Million
1,470,987 Added 27.9%
6,743,844 $451 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $44.3 Million - $49.9 Million
747,373 Added 16.51%
5,272,857 $333 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $4.64 Million - $5.26 Million
-80,389 Reduced 1.75%
4,525,484 $281 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $3.62 Million - $4.01 Million
62,953 Added 1.39%
4,605,873 $270 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $3.33 Million - $3.89 Million
60,679 Added 1.35%
4,542,920 $267 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $10.1 Million - $14.7 Million
217,750 Added 5.11%
4,482,241 $259 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $33.6 Million - $43.9 Million
683,684 Added 19.09%
4,264,491 $274 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $47.4 Million - $56.3 Million
-1,109,325 Reduced 23.65%
3,580,807 $180 Million
Q2 2019

Aug 08, 2019

BUY
$44.62 - $49.34 $12.1 Million - $13.3 Million
270,185 Added 6.11%
4,690,132 $213 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $17.5 Million - $20.8 Million
387,057 Added 9.6%
4,419,947 $211 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $30 Million - $38.9 Million
615,786 Added 18.02%
4,032,890 $210 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $24 Million - $27.1 Million
-434,644 Reduced 11.28%
3,417,104 $212 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $157 Million - $196 Million
3,109,664 Added 419.04%
3,851,748 $213 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $5.27 Million - $6.07 Million
87,983 Added 13.45%
742,084 $46.9 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $5.71 Million - $6.22 Million
95,204 Added 17.03%
654,101 $40.1 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $30.9 Million - $35.6 Million
558,897
558,897 $35.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.